28 February 2017

NADP takes the next step towards new antibiotics and alternatives

Within the Netherlands Antibiotic Development Platform (NADP), knowledge institutions and the business community will work together to develop new antibiotics and alternatives. The core mission of NADP is to bring companies and research groups together to accelerate research into the development of new antibiotics and alternatives to antibiotics. NADP will thereby focus on organisations that work on the treatment and prevention of bacterial infections in humans and animals. A new public-private research programme by the Netherlands Organisation for Scientific Research (NWO) domain Applied and Technical Sciences (NWO TTW) will support these developments.

Netherlands Centre for One Health (NCOH) is partner of the NADP.

With the increase in antibiotics resistance, bacterial infections pose an ever-growing threat to the health of humans and animals. Every year, thousands of people die worldwide due to antibiotics resistance, and that number will only grow if no new solutions for the treatment and prevention of bacterial infections are developed.

Partnership platform
NADP facilitates partnerships between companies and research groups working on the development of new antibiotics, both in the form of new molecules and pre-clinical development, as well as alternatives to antibiotics, such as vaccines. The NADP partners are the Netherlands Centre for One Health (NCOH) in Utrecht, the Centre for Antimicrobial Research (CARES) in Leiden, the Center for Sustainable Antimicrobials (CeSAM) in Groningen, and Immuno Valley in Utrecht. The independent Chairman of NADP is Kees de Joncheere, former Director Department of Essential Medicines and Health Products at the World Health Organization.

Since 2016, research groups in the Netherlands collaborate in the field of antimicrobial resistance, new antibiotics, and alternatives as part of the NCOH Strategic Research Theme ‘Tackling Antimicrobial Resistance’. NADP strives to bring these groups together with the business community to accelerate the development of these new antibiotics and alternatives.

NWO TTW research programme
A research programme by the NWO TTW will support the acceleration of the development of new antibiotics and alternatives. The Ministry of Public Health, Welfare and Sport, the NWO, and the Topsector Chemistry have made approximately 6 million Euros available for this programme. The NWO TTW programme is expected to open this call for public-private project proposals in late April 2017.

Kickoff
On 18 April 2017, NADP will officially be launched at a kick-off event with a matchmaking session in Utrecht. The goal of the matchmaking session is to bring potential partners together for new project applications, including those for the NWO TTW call, which will be presented in a plenary session as part of the programme. For more information about NADP and the launch event, please visit nadp.nl.

NADP background
NADP was founded by the partners with the support of the Ministry of Public Health, Welfare, and Sport and the Topsector Life Sciences & Health, after consultations with companies and knowledge institutions working in the field of antimicrobial resistance. The results of these consultations, conducted by InnoTact Consulting and concluded with a final report to the Ministry, were used to bring together the NADP partners and to draw up plans of action for NADP.